3
Announcements
Trials
Browse
Landscape
Status
Completed
108
Recruiting
54
Unknown
40
Terminated
39
Active not recruiting
25
Not yet recruiting
13
Withdrawn
10
Enrolling by invitation
2
Suspended
1
No longer available
1
Available
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Observational
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Plasma cell
1
Genitourinary
1
Conditions
Neoplasms
12
Hematologic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Urinary Bladder Neoplasms
4
Leukemia, Myeloid, Acute
4
Colorectal Neoplasms
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Myasthenia Gravis
3
Multiple Myeloma
3
Lung Neoplasms
3
Kidney Neoplasms
3
Carcinoma, Hepatocellular
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Heart Failure
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Diabetes Mellitus, Type 2
2
Interventions
Inosine Monophosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
INDUSTRY
×
Lymphoma, B-Cell
×
Clear all
NCT07474051
2026-03-16
PERSIST
AvenCell Therapeutics, Inc.
Enrolling by invitation
178 enrolled
NCT05332054
2026-03-12
LTFS
Caribou Biosciences, Inc.
Enrolling by invitation
150 enrolled